K
Keythera Pharmaceuticals
Innovative cancer therapies leveraging advanced biotechnology for targeted treatment solutions
About Keythera Pharmaceuticals
Keythera Pharma specializes in the development of innovative cancer therapies using advanced biotechnology. The company focuses on creating targeted treatment solutions that aim to improve patient outcomes and quality of life. Keythera Pharma serves healthcare providers, research institutions, and pharmaceutical companies within the oncology market. The business model revolves around research and development, clinical trials, and partnerships with other entities in the healthcare sector. Revenue is generated through licensing agreements, research grants, and sales of proprietary treatments. Keythera Pharma has been recognized for its technological innovation and high growth potential, winning several awards and accolades in the industry.
Source: Dealroom company dataAt a glance
- Founded
- 2020
- Headquarters
- Suzhou Shi, China
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Yijing Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Keythera Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Keythera Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.